Objectif
Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) represents a major European health care concern with mortality rates between 40-70%. Approximately 70-80% of these patients present with multivessel disease defined as coronary lesions in more than one vessel. The clinician is faced with the decision to either 1) intervene only on the culprit lesion acutely responsible for the initiation of cardiogenic shock, or 2) treat additional lesions considered hemodynamically significant but not acutely triggering the CS cascade as well. Current guidelines recommend percutaneous coronary intervention of all critical lesions. However, due to a lack of randomized trials, these recommendations are solely based on registry data and pathophysiological considerations. Aim of the randomized CULPRIT-SHOCK trial is therefore to compare a) immediate multivessel PCI versus b) culprit lesion only PCI in patients with AMI complicated by CS. A total of 706 CS patients will be randomized in several European countries. The primary endpoint will be 30-day all-cause mortality and/or severe renal failure requiring renal replacement therapy. CULPRIT-SHOCK will therefore determine the optimal percutaneous revascularization strategy in patients with AMI and multivessel disease complicated by CS. In addition, a comprehensive array of efficacy, safety and socio-economic parameters for the chosen population will be assessed. Multiple secondary endpoints and several substudies (microcirculation, biomarkers, angiography) will serve to further understand the presumed differential effects of the 2 treatment arms and to understand the underlying pathophysiology and prognostic markers. From these parameters a multivariable regression model and a risk score for the prediction of clinical prognosis and a cost-effectiveness model in AMI and CS will be developed. Furthermore, CULPRIT-SHOCK will obtain data on CS patients not meeting inclusion criteria by instituting a separate registry.
Champ scientifique
Appel à propositions
FP7-HEALTH-2013-INNOVATION-1
Voir d’autres projets de cet appel
Régime de financement
CP-FP - Small or medium-scale focused research projectCoordinateur
23562 Lubeck
Allemagne
Voir sur la carte
Participants (23)
67063 LUDWIGSHAFEN
Voir sur la carte
1105AZ Amsterdam
Voir sur la carte
Participation terminée
1160 WIEN
Voir sur la carte
LT-08661 Vilnius
Voir sur la carte
75012 Paris
Voir sur la carte
75013 PARIS
Voir sur la carte
1000 Ljubljana
Voir sur la carte
04 628 Warszawa
Voir sur la carte
3010 BERN
Voir sur la carte
Participation terminée
751 05 Uppsala
Voir sur la carte
G12 8QQ Glasgow
Voir sur la carte
42100 Reggio Emilia
Voir sur la carte
Participation terminée
42100 REGGIO EMILIA
Voir sur la carte
Participation terminée
80333 Muenchen
Voir sur la carte
04109 Leipzig
Voir sur la carte
G81 4HX GLASGOW
Voir sur la carte
04289 Leipzig
Voir sur la carte
Participation terminée
23900 LECCO
Voir sur la carte
23900 Lecco
Voir sur la carte
2650 Edegem
Voir sur la carte
75008 Paris
Voir sur la carte
1060 WIEN
Voir sur la carte
3010 Bern
Voir sur la carte